20728-75-0 Usage
General Description
The chemical compound "(2R-trans)-2-[3,4-bis(phenylmethoxy)phenyl]-3,4-dihydro-3-methoxy-5,7-bis(phenylmethoxy)-2H-1-benzopyran," also known as trans-Rose Bengal, is a synthetic dye and a derivative of rose bengal. It is commonly used as a staining agent in medical and biological research, particularly in ophthalmology to identify damaged eye cells. Rose Bengal is also being investigated for its potential use in photodynamic therapy for cancer treatment. It is a photoactivatable compound, meaning that it can become toxic upon exposure to light, and is being studied for its applications in targeted cancer therapy and antimicrobial applications. Rose Bengal is also used in various industrial processes, such as in the production of colorants and as a stain in histology.
Check Digit Verification of cas no
The CAS Registry Mumber 20728-75-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,7,2 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 20728-75:
(7*2)+(6*0)+(5*7)+(4*2)+(3*8)+(2*7)+(1*5)=100
100 % 10 = 0
So 20728-75-0 is a valid CAS Registry Number.
InChI:InChI=1/C44H40O6/c1-45-43-27-38-40(48-30-34-18-10-4-11-19-34)25-37(46-28-32-14-6-2-7-15-32)26-41(38)50-44(43)36-22-23-39(47-29-33-16-8-3-9-17-33)42(24-36)49-31-35-20-12-5-13-21-35/h2-26,43-44H,27-31H2,1H3/t43-,44+/m0/s1
20728-75-0Relevant articles and documents
FLAVONOID COMPOUNDS
-
, (2014/09/29)
The present invention relates to compounds, compositions, and methods for treatment of conditions related to mitochondrial function. In various aspects, the present invention comprises administering one or more epicatechin derivatives in an amount effective to stimulate mitochondrial function in cells. The compounds, compositions, and methods described herein provide for reducing infarct size in the heart following permanent ischemia or ischemia/reperfusion event or method for delaying, attenuating or preventing adverse cardiac remodeling, and can assist in prevention of impaired mitochondria biogenesis and thus prevention of the consequences of impaired mitochondrial biogenesis in various diseases and conditions, as well as provide for the active therapy of mitochondrial depletion that may have already occurred.
